FDA Investigator Charles M Edwards

Charles M Edwards has inspections in 13 countries as of 27 Oct 2023. Charles M Edwards has collaborated with a combinined 5969 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
67
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
China, United Kingdom of Great Britain and Northern Ireland, United States of America, Canada, Switzerland, Slovenia, Japan, Italy, India, Romania, Thailand, Slovakia
Co-Investigator(s):
Ademola O Daramola, Alan P Kurtzberg, Alberto A Viciedo, Albinus M D Sa, Alice S Tsao, Amy L Singer, Amy M Cramer, Anastasia G Lolas, Anastasia M Shields, Andre S Raw, Andrea A Branche, Andrea Dcharles Julien, Angela E Glenn, Anissa M Vargas, Anita R Michael, Ann L Demarco, Ann Marie Montemurro, Anna Lazar, Annemarie Bodnar, Anthony A Charity, Anthony C Warchut, Anthony J Ladner, Arsen Karapetyan, Audrey Thereset Uy, Aurora Miha Trifanov, Azza Talaat, Barbara J Rincon, Barbara Janine Breithaupt, Barry Rothman, Bichsa T Tran, Bo Chi, PhD, Bonita S Chester, Brandon C Heitmeier, Brian D Nicholson, Brian L Belz, Bryan L Mcguckin, Byungja E Marciante, Carl A Anderson, Carl A Huffman, III, Carl Lee, Carla A Norris, Carla J Lundi, Caryn M Mcnab, CDR Thomas R Berry, PPh, Charisse K Green, Charles A Snipes, PhD, Charles D Brown, Charles I Ann, Charles L Zhou, Charles M Edward, Charles R Cote, RIC, Cheryl A Clausen, Chiang Syin, PhD, Christina A Miller, Christopher D Leach, Christopher R Czajka, Christopher T Middendorf, Claire M Minden, Cody D Rickman, Colleen M Damon, Constantin Y Philopoulos, Craig D Zagata, Cynthia A Palmer, Cynthia J Lee, MS, Cynthia M Goudeau, Dale A Nyberg, Dana M Klimavicz, Daniel J Grabicki, Darren S Brown, David J Eide, David M Beltran, Dawn E Barkans, Debra I Love, Debra J Bennett, Dell S Moller, Denise M Digiulio, Denise M Visco, Investigator, Dennis Cantellops Paite, Deyaa Shaheen, Dillard H Woody, Jr, Djamila Harouaka, Doan T Nguyen, PharmD, Don H Bark, PhD, Donald L Lech, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Chunchang Fang, Dr. Jason R Caballero, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edward Oshaughnessy, Edwards, Edwin Martinez, Eileen A Liu, Emest F Bizjak, Emily J Orban, Eric L Dong, BS, Eric S Weilage, Erika V Butler, Farhana Khan, Felix Maldonado, Francis A Guidry, Gam S Zamil, Gayle S Lawson, George J Flynn, Geraldine D Sanders, Geraldine Sanders, Ginger M Sykes, Guo Q Shen, Gwyn G Dickinson, Hala L Selby, Helen B Ricalde, Ivan E Reyes, Ivis Lnegron Torres, Jaison J Eapen, James A Liubicich, James C Illuminati, James C Maclaughlin, James I Giefer, James L Dunnie, Jr, James P Stumpff, Jamie L Dion, Jason F Chancey, Jason P Aun, Javier O Vega, Jawaid Hamid, Jean Blackston Hill, Jean Blackstone Hill, Jeffery A Hangartner, Jeffrey A Sommers, Jeffrey P Raimondi, Jessica L Pressley, Joanne Heim, Joanne M Hajoway, Joel D Hustedt, Joey V Quitania, John A Gonzalez, John D White, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Jose R Hernandez, Joseph J Vannelli, Joseph Joseph, L Despins, Joseph L Despins, PhD, Joseph R Lambert, Joy Rkozlowski Klena, Julianne C Mccullough, Julie D Bringger, Jullianne C Mccullough, Junho Pak, Justin A Boyd, Karyn M Campbell, Katherine E Jacobitz, Katherine Szestypalow, Kathryn E Ogger, Kelli F Dobilas, Kenneth H Williams, Kenneth R Merritt, Kent C Faul, Kevin D Kallander, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Kristen D Evans, Kristina J Donohue, Kristina Mjoyce Pittman, Kristy A Zielny, Kristy E Zuroski, Larry K Austin, Lata C Mathew, PhD, Laura B Kennedy, Laura Fontan, MS, Lauren N Howard, Laurie B Frazier, Laurie Nelson, Laurimer Kuilan Torres, Lequita M Mayhew, Liatte Kreuger, PharmD, Lillie D Witcher, Linda F Murphy, Lindsey M Schwierjohann, Liqun Zhao, Lisa B Orr, Lisa M Bellows, Lloyd D Payne, Loretta Nemchik, Luella J Rossi, Luis A Dasta, Lydia Irosas Marty, Lynda L Perry, PhD, Lynnette I Riggio, Marcellinus D Dordunoo, Marcus F Yambot, Marea K Harmon, Margaret L Bolte, Margaret M Annes, Margaret M Sands, Marian E Ramirez, Marie F Morin, Marijo B Kambere, PhD, Marion Michaelis, Martin K Yan, PhD, Martin Yan, Mary E Storch, Matthew B Casale, Matthew C Watson, Matthew J Johnson, Matthew R Noonan, Maxwell Van Tassell, PhD, Meisha R Sampson, Meisha Waters, Melba Trivera Clavell, Michael A Charles, Michael E Maselli, Michael Gurbarg, Michael L Casner, Michael P Sheehan, Michael R Goga, Michael S Smoker, Michael Serrano, Michael Shanks, MS, Michele L Obert, Miguel A Martinez, Mindy M Chou, Minh D Phan, Monica E Caphart, Monika Borkowska, Mra B Kamberem, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Neal L Adams, Nebil A Oumer, Nicholas A Violand, Nicolas Riveratorres, Nicole E Knowlton, Nilufer M Tampal, PhD, Nilufer M Tampalm, PhD, Noreen Muniz, Omotunde O Osunsanmi, Pankaj H Amin, Parul M Patel, Patricia A Cochran, Patricia Fhughes Troost, Patricia H Dlugosz, Patrick C Klotzbuecher, Patrick L Wisor, Paul L Bellamy, Penny H Mccarver, Peter C Chow, Peter E Baker, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Ramesh Potla, PhD, Raymond T Oji, Reba A Gates, Rebecca Rodriguez, Regina T Brown, Richard E Needham, Robert B Shibuya, MD, Robert C Coleman, Robert J Maffei, Robert J Martin, Robert M Barbosa, Rochelle L Cross, Rory K Geyer, Roy Baby, Roy C Stephens, Russell J Glapion, Russell K Riley, S Lori Brown, PhD MPH, Saied A Asbagh, Saleem A Akhtar, Sam Pepe, Sandra A Hughes, Sanket N Patel, Sarah E Mcmullen, Sarah Forney, Sarah M Meng, Sarah M Napier, Satheesh Thomas, Scott T Ballard, Seneca D Toms, Sharon K Thoma, PharmD, Shelby N Turner, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Sina Shojaee, Sneha S Patel, Sony Mathews, Sriram Susrambraham, State Agency, Stephen D Brown, Stephen J Kilker, Stephen J Koniers, Steven D Kehoe, Steven M Weinman, Susan D Yuscius, Susan F Laska, MS, Susan W Ting, Susanna E Ford, Analyst, Susanne M Richardson, MSc RAC ELS, Susant Hadman, Syed N Ali, Tamil Arasu, PhD, Temar Q Williams, Thomas E Friel, Tiara Nbrown Crosen, Tonia F Bernard, Tracey L Siebesma, Truong Xuan Nguyen (Andy), Ucheabuchi C Chudi Nwankwor, Uduak M Inokon, Vincent F Cafiso, Vlada Matusovsky, Walden H Lee, William J Leonard, Yanming An, PhD, Yasamin Ameri, Yumi J Hiramine, Yvesna C Blaise, Yvette I Henry, Yvette I Johnson, Zachary L Miller, Zhong Li, PhD, Zhongren Wu, Zi Qiang Gu

Charles M Edwards's Documents

Publish Date Document Type Title
January, 2001 FDA 483 Erregierre SpA - Form 483, 2001-01-31
January, 2001 EIR Erregierre SpA - EIR, 2001-04-05
February, 2002 FDA 483 Arch Pharmalabs Limited - Form 483, 2002-02-19
February, 2002 FDA 483 NEULAND LABORATORIES LIMITED - Form 483, 2002-02-12
September, 2001 FDA 483 Chongqing Daxin Pharmaceutical Co., Ltd. - Form 483, 2001-09-25
January, 2001 FDA 483 Response Reckitt Benckiser (UK) Ltd. - Form 483R, 2001-01-19
February, 2002 EIR NEULAND LABORATORIES LIMITED - EIR, 2002-02-12
August, 2001 FDA 483 Fukuzyu Pharmaceutical Co., Ltd. - Form 483, 2001-08-29
June, 2000 FDA 483 SICOR SpA - Form 483, 2000-06-19
June, 2001 EIR E.R. Squibb & Sons, L.L.C. - EIR, 2001-06-08
June, 2003 EIR Siegfried AG - EIR, 2003-06-12
January, 2001 FDA 483 Bachem AG - Form 483, 2001-01-25
September, 2005 FDA 483 Response Evonik Corporation - Form 483R, 2005-09-16
June, 2003 FDA 483 Response Siegfried AG - Form 483R, 2003-09-09
November, 2002 EIR Neopharm Labs Inc. - EIR, 2005-03-25
June, 2000 EIR Sicor Societa' Italiana Corticosteroidi s.r.l - EIR, 2000-06-19
July, 2002 EIR Antibiotice SA - EIR, 2002-07-10
June, 2000 FDA 483 TEVA PHARMACEUTICAL FINE CHEMICALS SRL. - Form 483, 2000-06-13
September, 2001 FDA 483 Zhejiang Shenghua Biok Biology Co., Ltd. - Form 483, 2001-09-19
June, 2000 FDA 483 Response Sicor Societa' Italiana Corticosteroidi s.r.l - Form 483R, 2000-09-28
February, 2002 FDA 483 Response NEULAND LABORATORIES LIMITED - Form 483R, 2002-03-20
May, 2000 EIR Suanfarma Italia S.p.A. - EIR, 2000-05-24
July, 2002 FDA 483 Response Lek d.d. - Form 483R, 2002-07-04
July, 2004 EIR Frontida BioPharm, LLC - EIR, 2004-07-19
July, 2002 FDA 483 Response Antibiotice SA - Form 483R, 2002-07-10
July, 2004 EIR Frontida BioPharm Inc. - EIR, 2004-07-22
June, 2000 EIR Corden Pharma Bergamo SpA - EIR, 2000-06-13
October, 2004 EIR Sumitomo Pharmaceuticals Co., Ltd. - EIR, 2005-02-09
March, 2006 FDA 483 Response Patheon Inc. - Form 483R, 2006-05-22
October, 2004 FDA 483 Response Sumitomo Pharmaceuticals Co., Ltd. - Form 483R, 2005-03-08
October, 2004 EIR Sumitomo Chemical Company, Limited - EIR, 2005-02-09
March, 2006 EIR Patheon Inc. - EIR, 2006-03-22
September, 2001 EIR Zhejiang Shenghua Biok Biology Co., Ltd. - EIR, 2001-09-19
January, 2001 FDA 483 Reckitt Benckiser (UK) Ltd. - Form 483, 2001-01-19
September, 2005 EIR Evonik Corporation - EIR, 2005-09-01
June, 2002 EIR BIOTIKA a.s. - EIR, 2002-06-12
June, 2003 FDA 483 Response Novartis Pharma AG - Form 483R, 2003-09-24
February, 2004 EIR Kyowa Hakko Bio Co. Ltd. - EIR, 2004-02-10
January, 2001 EIR Reckitt Benckiser (UK) Ltd. - EIR, 2001-01-19
February, 2004 EIR Fuji Chemical Industries Co., Ltd. - EIR, 2004-05-05
August, 2001 EIR Fukuzyu Pharmaceutical Co., Ltd. - EIR, 2001-08-29
January, 2001 EIR Bachem AG - EIR, 2001-03-13
September, 2005 FDA 483 Evonik Corporation - Form 483, 2005-09-01
January, 2001 FDA 483 Response Erregierre SpA - Form 483R, 2001-05-02
August, 2001 FDA 483 Response Fukuzyu Pharmaceutical Co., Ltd. - Form 483R, 2001-09-04
June, 2000 FDA 483 Response Corden Pharma Bergamo SpA - Form 483R, 2000-06-13
July, 2002 EIR Lek d.d. - EIR, 2002-07-26
September, 2001 EIR Chongqing Daxin Pharmaceutical Co., Ltd. - EIR, 2005-05-26

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more